Misook Yu

Array ( [id] => 11032962 [patent_doc_number] => 20160229918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/904312 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24865 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685741 [patent_doc_number] => 20160031887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/774531 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59355 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467178 [patent_doc_number] => 20150352193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/760809 [patent_app_country] => US [patent_app_date] => 2014-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11804 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10443298 [patent_doc_number] => 20150328310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'METHODS AND COMPOSITIONS RELATING TO TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/652363 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16634 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10408096 [patent_doc_number] => 20150293104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER' [patent_app_type] => utility [patent_app_number] => 14/413846 [patent_app_country] => US [patent_app_date] => 2012-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15835 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101675 [patent_doc_number] => 20110165167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'NOVAL MADCAM ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/051532 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20649 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165167.pdf [firstpage_image] =>[orig_patent_app_number] => 13051532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6001649 [patent_doc_number] => 20110117555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'CD38 as a prognostic indicator in chronic lymphocytic leukemia' [patent_app_type] => utility [patent_app_number] => 12/927687 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8758 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117555.pdf [firstpage_image] =>[orig_patent_app_number] => 12927687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190114 [patent_doc_number] => 20110172398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'BISPECIFIC BINDING MOLECULES FOR ANTI-ANGIOGENESIS THERAPY' [patent_app_type] => utility [patent_app_number] => 12/894989 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 130 [patent_figures_cnt] => 130 [patent_no_of_words] => 36874 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172398.pdf [firstpage_image] =>[orig_patent_app_number] => 12894989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561962 [patent_doc_number] => 20100272738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'ANTI-OX40L ANTIBODIES AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/834748 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40711 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272738.pdf [firstpage_image] =>[orig_patent_app_number] => 12834748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392182 [patent_doc_number] => 20100303834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 12/827590 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 249 [patent_figures_cnt] => 249 [patent_no_of_words] => 86231 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12827590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148627 [patent_doc_number] => 20110020222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'MODIFIED ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/789955 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20902 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020222.pdf [firstpage_image] =>[orig_patent_app_number] => 12789955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024249 [patent_doc_number] => 20110052575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/768089 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30280 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052575.pdf [firstpage_image] =>[orig_patent_app_number] => 12768089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6558907 [patent_doc_number] => 20100233711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/725414 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8470 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233711.pdf [firstpage_image] =>[orig_patent_app_number] => 12725414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270676 [patent_doc_number] => 20100254979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Humanized PAI-1 Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/719733 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 71581 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254979.pdf [firstpage_image] =>[orig_patent_app_number] => 12719733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038405 [patent_doc_number] => 20110091454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'METHODS AND SYSTEMS FOR ANNOTATING BIOMOLECULAR SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/701651 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 95044 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091454.pdf [firstpage_image] =>[orig_patent_app_number] => 12701651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247180 [patent_doc_number] => 20100136581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 12/625729 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14760 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136581.pdf [firstpage_image] =>[orig_patent_app_number] => 12625729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576167 [patent_doc_number] => 07825220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Tumor suppressor gene' [patent_app_type] => utility [patent_app_number] => 12/626290 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 15533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825220.pdf [firstpage_image] =>[orig_patent_app_number] => 12626290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6417827 [patent_doc_number] => 20100167321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED EP-CAM-SPECIFIC CTL AND USE OF THE SAME' [patent_app_type] => utility [patent_app_number] => 12/564320 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13919 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167321.pdf [firstpage_image] =>[orig_patent_app_number] => 12564320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379329 [patent_doc_number] => 20100081795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'RG1 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/560363 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17573 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081795.pdf [firstpage_image] =>[orig_patent_app_number] => 12560363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371330 [patent_doc_number] => 20100075345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHOD OF SCREENING' [patent_app_type] => utility [patent_app_number] => 12/560403 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11219 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075345.pdf [firstpage_image] =>[orig_patent_app_number] => 12560403 [rel_patent_id] =>[rel_patent_doc_number] =>)